Abiomed

$302.02 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Abiomed

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Stock Analysis

last close $292.38
1-mo return -7.3%
3-mo return -16.7%
avg daily vol. 345.25T
52-week high 387.4
52-week low 261.27
market cap. $13.7B
forward pe 67.3
annual div. -
roe 11.6%
ltg forecast 10.5%
dividend yield -
annual rev. $974M
inst own. 92.6%
baraka

Subscribe now for daily local and international financial news

Subscribe